Article

Docs Oppose California Assisted Suicide Bill

Author(s):

California's "End of Life Option Act" faces stiff opposition from the American College of Physicians. The bill will become state law unless California's Gov. Jerry Brown vetoes it.

California's "End of Life Option Act" faces stiff opposition from the American College of Physicians. The bill will become state law unless California's Gov. Jerry Brown vetoes it.

Today the ACP's President Wayne Riley, MD, MPH, MBA, MACP released a strongly worded letter he sent to Brown asking him to do just that.

Riley said the measure essentially asks physicians to abandon the dying patient. "It is not the role of the physician to give individuals control over the cause and timing of death--the medicalization of suicide," he wrote.

Rather than being an act of compassion, facilitating suicide "undermines trust in patient-physician relationships and trust in the profession of medcine," Riley continued.

The measure also plays on patients' fears that they will not have access to pain relief should they need it. But physicians already have an obligation to alleviate pain and other symptoms and to do so "with competence and compassion."

That means that "aggressive managment of pain at the end of life is ethically acceptable, even when the risk of hastening death is foreseeable," according to the group's code of ethics, he wrote.

Physician-assisted suicide has also been held a different issue from patients' right to refuse treatmtnets in several court decisions, he said.

Finally, Riley noted, it is ironic that a state is trying to help physicians end patients lives when it falls far short of guaranteeing that they have a right to life-sustaining forms of medical care--such as health care for those without insurance.

"We also note the paradox of access to physician assisted suicide whre there is no right to general health care," Riley said.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.